These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6594239)

  • 1. Susceptibility of Mycobacterium fallax to imipenem and twenty other antimicrobial agents.
    Haas H; Zubi R; Sacks TG
    Eur J Clin Microbiol; 1984 Oct; 3(5):489-91. PubMed ID: 6594239
    [No Abstract]   [Full Text] [Related]  

  • 2. BO-2727, meropenem and imipenem disc diffusion susceptibility testing criteria.
    Barry AL; Fuchs PC
    J Antimicrob Chemother; 1995 Aug; 36(2):444-6. PubMed ID: 8522478
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimicrobial activity of imipenem and SCH34343 against Legionella species.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1987 Apr; 6(4):307-9. PubMed ID: 3472705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro sensitivity of Bacteroidaceae, clostridia and propionibacteria to newer antimicrobial agents.
    Höffler U
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():41-6. PubMed ID: 3469196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RO23-6240, a new orally absorbed quinolone: in vitro comparison with other broad-spectrum oral antimicrobial agents and imipenem.
    Aldridge KE; Schiro DD; Sanders CV
    Diagn Microbiol Infect Dis; 1987 May; 7(1):9-19. PubMed ID: 3121244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of meropenem and imipenem against mycobacteria: development of a daily antibiotic dosing schedule.
    Watt B; Edwards JR; Rayner A; Grindey AJ; Harris G
    Tuber Lung Dis; 1992 Jun; 73(3):134-6. PubMed ID: 1421344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program.
    Turner PJ
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):341-4. PubMed ID: 17049798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic susceptibilities of the Vibrionaceae to meropenem and other antimicrobial agents.
    Clark RB
    Diagn Microbiol Infect Dis; 1992 Jul; 15(5):453-5. PubMed ID: 1643823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Ishag AJ; Durgham SM; Shibl AM
    Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of Legionella spp. to imipenem and 27 other beta-lactam antibiotics.
    Ruckdeschel G; Ehret W; Ahl A
    Eur J Clin Microbiol; 1984 Oct; 3(5):463-7. PubMed ID: 6594234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro efficacy of imipenem in combination with six antimicrobial agents against Mycobacterium abscessus.
    Miyasaka T; Kunishima H; Komatsu M; Tamai K; Mitsutake K; Kanemitsu K; Ohisa Y; Yanagisawa H; Kaku M
    Int J Antimicrob Agents; 2007 Sep; 30(3):255-8. PubMed ID: 17616451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of group B streptococci.
    Persson KM; Forsgren A
    Eur J Clin Microbiol; 1986 Apr; 5(2):165-7. PubMed ID: 2941275
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance to imipenem in Pseudomonas aeruginosa.
    King A; Shannon K; Phillips I
    J Antimicrob Chemother; 1995 Dec; 36(6):1037-41. PubMed ID: 8821603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antibacterial activities of doripenem, imipenem, and meropenem against recent Streptococcus pneumoniae isolates.
    Baek JY; Ko KS; Kang CI; Song JH; Peck KR
    Diagn Microbiol Infect Dis; 2011 Nov; 71(3):297-300. PubMed ID: 21855246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Comparison of Ertapenem, Meropenem, and Imipenem against Isolates of Rapidly Growing Mycobacteria and Nocardia by Use of Broth Microdilution and Etest.
    Brown-Elliott BA; Killingley J; Vasireddy S; Bridge L; Wallace RJ
    J Clin Microbiol; 2016 Jun; 54(6):1586-1592. PubMed ID: 27053677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting doripenem susceptibility based on meropenem and imipenem interpretation for Pseudomonas aeruginosa.
    Hagihara M; Kuti JL; Nicolau DP
    Diagn Microbiol Infect Dis; 2012 Mar; 72(3):258-62. PubMed ID: 22209563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae.
    Pikis A; Donkersloot JA; Akram S; Keith JM; Campos JM; Rodriguez WJ
    J Antimicrob Chemother; 1997 Jul; 40(1):105-8. PubMed ID: 9249211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro interactions of DX-8739, a new carbapenem, meropenem and imipenem with amikacin against multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Grecka P; Giamarellou H
    J Antimicrob Chemother; 1996 Aug; 38(2):287-91. PubMed ID: 8877544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect Tris-EDTA Disk Testing Using Imipenem and Meropenem for Detection of OXA-48 Carbapenemase Production.
    Thomson GK; AbdelGhani S; Snyder JW; Thomson KS
    J Clin Microbiol; 2015 Nov; 53(11):3705-6. PubMed ID: 26292309
    [No Abstract]   [Full Text] [Related]  

  • 20. Postantibiotic effect of imipenem, alone and in combination with amikacin, on Pseudomonas aeruginosa.
    Gerçeker AA; Otük G
    Chemotherapy; 1995; 41(6):433-6. PubMed ID: 8529433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.